Physician

Kairav Rameshchandra Shah, MD

According to 2025 Medicare claims, Kairav Shah, MD (NPI: 1053660886) practices interventional pain management (ipm) in the Modesto, CA market, with the plurality of this provider's patient population coming from Stanislaus, CA. This provider's primary affiliated billing organization is INTEGRATED PAIN MANAGEMENT MEDICAL GROUP, INC. (NPI: 1922198779; TIN: 680477806) and primary practice location at 95350-4573. Shah is affiliated with the HHC ACO Inc (ACO ID: A1675) and Sunflower ACO LLC (ACO ID: A5499), participating under the MSSP model.

Shah's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 354 traditional Medicare patients, billed 4,794 HCPCS/CPT codes, and received $384,699 in Medicare payments. The top billing code was G0483 (Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms). Part D data shows 2,226 prescription claims across 316 beneficiaries totaling $113,096 in drug costs, led by Hydrocodone-Acetaminophen (Hydrocodone/Acetaminophen). Open Payments data shows 5 records totaling $91. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $36,525 to $384,699. Similarly, Part D prescription costs have moved sharply higher in recent years, from $50,677 to $113,096. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$192K$385K2015 Medicare payment: $36,525 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $10,300 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $5,325 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $5,824 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $20,656 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $16,058 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $59,319 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $384,258 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $245,031 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $384,699 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015225537$36,525
201672178$10,300
20173366$5,325
20183490$5,824
2019209313$20,656
2020132264$16,058
202161741$59,319
20223314,295$384,258
20233423,087$245,031
20243544,794$384,699

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$95K$190K2015 Drug cost: $50,677 (USD; Tot_Drug_Cst)2016 Drug cost: $42,707 (USD; Tot_Drug_Cst)2017 Drug cost: $48,152 (USD; Tot_Drug_Cst)2018 Drug cost: $113,028 (USD; Tot_Drug_Cst)2019 Drug cost: $69,807 (USD; Tot_Drug_Cst)2020 Drug cost: $73,573 (USD; Tot_Drug_Cst)2021 Drug cost: $62,836 (USD; Tot_Drug_Cst)2022 Drug cost: $189,504 (USD; Tot_Drug_Cst)2023 Drug cost: $142,276 (USD; Tot_Drug_Cst)2024 Drug cost: $113,096 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
201585855$50,677
201684656$42,707
201779728$48,152
2018981,455$113,028
20193061,352$69,807
20205121,259$73,573
20212701,038$62,836
20222952,705$189,504
20233381,969$142,276
20243162,226$113,096

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
G0483Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms207550$241
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more2641,555$98
99443Telephone medical discussion with physician, 21-30 minutes121153$93
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more111164$67
99442Telephone medical discussion with physician, 11-20 minutes160276$67

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen62417,995$22,378
OxycontinOxycodone Hcl26715$12,805
MovantikNaloxegol Oxalate15450$5,960
LidocaineLidocaine451,120$4,698
Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl19620$3,678

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.5$91Averitas Pharma Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Kairav Rameshchandra Shah, MD?

Tedicare shows public-source Medicare data for Kairav Rameshchandra Shah, MD (NPI 1053660886), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Kairav Rameshchandra Shah, MD have ACO affiliation data?

Kairav Rameshchandra Shah, MD is shown with ACO affiliation data for HHC ACO Inc (MSSP, ACO ID A1675) and Sunflower ACO LLC (MSSP, ACO ID A5499).

What billing organization is linked to Kairav Rameshchandra Shah, MD?

Kairav Rameshchandra Shah, MD is linked to INTEGRATED PAIN MANAGEMENT MEDICAL GROUP, INC. (billing NPI 1922198779) in the available physician profile data.

Does Kairav Rameshchandra Shah, MD have Open Payments data?

Kairav Rameshchandra Shah, MD has 5 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.